Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Lung Cancer Clinical Trials, Blood-Based Biomarkers

David Gandara

MD

🏢UC Davis Comprehensive Cancer Center🌐USA

Professor of Medicine Emeritus

65
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

David Gandara at UC Davis is a veteran lung cancer clinical trialist who has made landmark contributions to the field over four decades. He championed blood-based tumor mutational burden (bTMB) as a biomarker for immunotherapy response in NSCLC and has led multiple SWOG cooperative group lung cancer trials. His contributions to lung cancer clinical research infrastructure and biomarker development have been foundational.

Share:

🧪Research Fields 研究领域

lung cancer
blood-based tumor mutation burden
liquid biopsy lung cancer
CODEBREAK trial
SWOG lung cancer

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-02-01 | All information from publicly available academic sources

关注 David Gandara 的研究动态

Follow David Gandara's research updates

留下邮箱,当我们发布与 David Gandara(UC Davis Comprehensive Cancer Center)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment